Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Weight loss to improve insulin sensitivity in insulin-resistant individuals

Official title: Reversal of Lipid-Induced Insulin Resistance

Run by Yale University · NCT02193295 · Data updated 2026-11-12

This study is testing if losing a little weight can help lean people who are insulin-resistant and have a family history of type 2 diabetes improve how their bodies handle sugar and fat.

More Insulin Resistance trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment250 (estimated)
SponsorYale University
Academic / other
Locations2 sites (New Haven, Connecticut and 1 other locations)
StatusRecruiting
StartedOctober 2002
Main results expectedOctober 2034
Study endsDecember 2034
Registry record updatedJune 22, 2026
Trial IDNCT02193295 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy, sedentary individuals with insulin resistance and a family history of type 2 diabetes.

Probably not a fit

Patients with systemic diseases, diabetes, or a history of eating disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether a small weight loss can reduce lipid content in muscle and liver, thereby improving insulin sensitivity in lean, insulin-resistant individuals with a family history of type 2 diabetes. Participants will undergo a series of metabolic assessments, including glucose metabolism and lipolysis measurements, before and after a caloric restriction intervention. The study aims to compare these effects with a control group of individuals without a family history of diabetes, using advanced techniques such as euglycemic hyperinsulinemic clamps and magnetic resonance spectroscopy.

Why it matters

Potential benefit: If successful, this study could lead to effective weight management strategies that improve insulin sensitivity and reduce the risk of type 2 diabetes in at-risk populations.

How similar studies have gone: Other studies have shown promising results in improving insulin sensitivity through weight loss in similar populations, indicating that this approach is supported by existing research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy, sedentary, non-smoking and not taking any medications other than birth control pills.
* Hematocrit \>35%
* Subjects will have no systemic or organ disease including diabetes.
* Subjects will have no history eating disorders.
* Women must be using a form of birth control (sexual abstinence, birth control pills, Norplant, IUD or condoms) and will be studied between day 0 and 7 of their menstrual cycle.
* Those who are taking birth control pills or have had a hysterectomy may be studied at any time.
* Physical activity will be assessed using a standard questionnaire with an activity index cut off at 2.3.

Exclusion Criteria:

* Any subject, who does not fit the inclusion criteria. Including history of eating disorders, any systemic and organ disease including diabetes.

Lactose intolerance Any blood count, clotting abnormalities HYpertriglyceridemeia (TG over 100 mg/dL)

* Hematocrit \<35%.
* Women of childbearing potential, who are not using contraception (as mentioned above) or who are not abstinent.
* Subjects who have a regular exercise regimen will not be enrolled.
* Metal implants and/or body piercing, which cannot be removed before the MR studies.

Where it's running

  • Yale Center for Clinical Investigation HRU
    New Haven, Connecticut, United States
    Recruiting
  • Magnetic Resonance Research Center (MRRC)
    New Haven, Connecticut, United States
    Enrolling by invitation

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.